NCT01540812 2020-03-09Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTSPETHEMA FoundationCompleted418 enrolled
NCT01889407 2015-04-21Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia PatientsNanfang Hospital, Southern Medical UniversityUnknown94 enrolled